Coronary Drug-Eluting Stent Infection Complicated by Coronary Artery Aneurysm and Purulent Pericarditis: Complete Resolution Without Surgery

Shuro Riku; Susumu Suzuki; Yasushi Jinno; Akihito Tanaka; Hideki Ishii; Toyoaki Murohara

doi:10.1016/j.cjca.2020.01.007

Coronary Drug-Eluting Stent Infection Complicated by Coronary Artery Aneurysm and Purulent Pericarditis: Complete Resolution Without Surgery

Shuro Riku, Susumu Suzuki, Yasushi Jinno, Akihito Tanaka, Hideki Ishii, Toyoaki Murohara

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Coronary stent infection is considered to be a rare but catastrophic complication of percutaneous coronary intervention. In this report, we present a 72-year-old man who developed a coronary stent infection complicated by coronary aneurysm and purulent pericarditis. Coronary artery aneurysm resolved over a period of 8 months following the successful management of infection with intensive antibiotic therapy alone. This case suggests that conservative therapy can be a therapeutic option in patients with high operative risks.

Original language	English
Pages (from-to)	967.e1-967.e3
Journal	Canadian Journal of Cardiology
Volume	36
Issue number	6
DOIs	https://doi.org/10.1016/j.cjca.2020.01.007
Publication status	Published - 06-2020
Externally published	Yes

All Science Journal Classification (ASJC) codes

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.cjca.2020.01.007

Cite this

@article{b45a9015303848e5b51889aa9c7f3347,

title = "Coronary Drug-Eluting Stent Infection Complicated by Coronary Artery Aneurysm and Purulent Pericarditis: Complete Resolution Without Surgery",

abstract = "Coronary stent infection is considered to be a rare but catastrophic complication of percutaneous coronary intervention. In this report, we present a 72-year-old man who developed a coronary stent infection complicated by coronary aneurysm and purulent pericarditis. Coronary artery aneurysm resolved over a period of 8 months following the successful management of infection with intensive antibiotic therapy alone. This case suggests that conservative therapy can be a therapeutic option in patients with high operative risks.",

author = "Shuro Riku and Susumu Suzuki and Yasushi Jinno and Akihito Tanaka and Hideki Ishii and Toyoaki Murohara",

note = "Funding Information: Dr Ishii received lecture fees from Astellas Pharma Inc, Astrazeneca Inc, Daiichi-Sankyo Pharma Inc, and MSD K.K. Dr Murohara received lecture fees from Bayel Pharmaceutical Co, Ltd; Daiichi-Sankyo Co, Ltd; Dainippon Sumitomo Pharma Co, Ltd; Kowa Co, Ltd; MSD K.K.; Mitsubishi Tanabe Pharma Co; Nippon Boehringer Ingelheim Co, Ltd; Novartis Pharma K.K.; Pfizer Japan In; Sanofi-Aventis K.K.; and Takeda Pharmaceutical Co, Ltd. Dr Murohara received unrestricted research grants for the Department of Cardiology, Nagoya University Graduate School of Medicine, from Astellas Pharma Inc; Daiichi-Sankyo Co, Ltd; Dainippon Sumitomo Pharma Co, Ltd; Kowa Co, Ltd; MSD K.K.; Mitsubishi Tanabe Pharma Co; Nippon Boehringer Ingelheim Co, Ltd; Novartis Pharma K.K.; Otsuka Pharma Ltd; Pfizer Japan Inc; Sanofi-Aventis K.K.; Takeda Pharmaceutical Co, Ltd; and Teijin Pharma Ltd. All other authors have reported that they have no conflicts of interest to disclose. Publisher Copyright: {\textcopyright} 2020 Canadian Cardiovascular Society",

year = "2020",

month = jun,

doi = "10.1016/j.cjca.2020.01.007",

language = "English",

volume = "36",

pages = "967.e1--967.e3",

journal = "Canadian Journal of Cardiology",

issn = "0828-282X",

publisher = "Pulsus Group Inc.",

number = "6",

}

TY - JOUR

T1 - Coronary Drug-Eluting Stent Infection Complicated by Coronary Artery Aneurysm and Purulent Pericarditis

T2 - Complete Resolution Without Surgery

AU - Riku, Shuro

AU - Suzuki, Susumu

AU - Jinno, Yasushi

AU - Tanaka, Akihito

AU - Ishii, Hideki

AU - Murohara, Toyoaki

N1 - Funding Information: Dr Ishii received lecture fees from Astellas Pharma Inc, Astrazeneca Inc, Daiichi-Sankyo Pharma Inc, and MSD K.K. Dr Murohara received lecture fees from Bayel Pharmaceutical Co, Ltd; Daiichi-Sankyo Co, Ltd; Dainippon Sumitomo Pharma Co, Ltd; Kowa Co, Ltd; MSD K.K.; Mitsubishi Tanabe Pharma Co; Nippon Boehringer Ingelheim Co, Ltd; Novartis Pharma K.K.; Pfizer Japan In; Sanofi-Aventis K.K.; and Takeda Pharmaceutical Co, Ltd. Dr Murohara received unrestricted research grants for the Department of Cardiology, Nagoya University Graduate School of Medicine, from Astellas Pharma Inc; Daiichi-Sankyo Co, Ltd; Dainippon Sumitomo Pharma Co, Ltd; Kowa Co, Ltd; MSD K.K.; Mitsubishi Tanabe Pharma Co; Nippon Boehringer Ingelheim Co, Ltd; Novartis Pharma K.K.; Otsuka Pharma Ltd; Pfizer Japan Inc; Sanofi-Aventis K.K.; Takeda Pharmaceutical Co, Ltd; and Teijin Pharma Ltd. All other authors have reported that they have no conflicts of interest to disclose. Publisher Copyright: © 2020 Canadian Cardiovascular Society

PY - 2020/6

Y1 - 2020/6

N2 - Coronary stent infection is considered to be a rare but catastrophic complication of percutaneous coronary intervention. In this report, we present a 72-year-old man who developed a coronary stent infection complicated by coronary aneurysm and purulent pericarditis. Coronary artery aneurysm resolved over a period of 8 months following the successful management of infection with intensive antibiotic therapy alone. This case suggests that conservative therapy can be a therapeutic option in patients with high operative risks.

AB - Coronary stent infection is considered to be a rare but catastrophic complication of percutaneous coronary intervention. In this report, we present a 72-year-old man who developed a coronary stent infection complicated by coronary aneurysm and purulent pericarditis. Coronary artery aneurysm resolved over a period of 8 months following the successful management of infection with intensive antibiotic therapy alone. This case suggests that conservative therapy can be a therapeutic option in patients with high operative risks.

UR - http://www.scopus.com/inward/record.url?scp=85084563346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084563346&partnerID=8YFLogxK

U2 - 10.1016/j.cjca.2020.01.007

DO - 10.1016/j.cjca.2020.01.007

M3 - Article

C2 - 32407676

AN - SCOPUS:85084563346

VL - 36

SP - 967.e1-967.e3

JO - Canadian Journal of Cardiology

JF - Canadian Journal of Cardiology

SN - 0828-282X

IS - 6

ER -

Coronary Drug-Eluting Stent Infection Complicated by Coronary Artery Aneurysm and Purulent Pericarditis: Complete Resolution Without Surgery

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this